top of page

Biological relationship//

DNA relationship testing is used to verify the existence of biological relationships between relatives. Types of relationship tests include paternity, maternity, sibling, grand parentage DNA testing can be used to confirm the biological relationship.

Fotolia_81323568_M (1).jpg

PATTERNITY TEST

 

DNA paternity test provides genetic evidence of whether a man is an individual's biological father. The test is obtained by applying a buccal swap (cotton-wrapped sterile plastic stick at the end of the buccal cells in the cheek) to 60 seconds into both cheeks, right and left.

DNA testing is the most advanced and accurate technology that determines to parent. It can be determined that the parent is 99.99% biologically relevant to the child, and 0% if not related. For paternity testing, samples of alleged father and child/children are needed.

46080170_2137010596548956_68264905772577

MATERNITY TEST

DNA maternity test provides genetic evidence of whether a woman is an individual's biological mother.

The test is obtained by applying a buccal swap (cotton-wrapped sterile plastic stick at the end of the buccal cells in the cheek) to 60 seconds into both cheeks, right and left. DNA testing is the most advanced and accurate technology that determines to parent. It can be determined that the parent is 99.99% biologically relevant to the child, and 0% if not related. For the motherhood test, samples of the alleged mother and child/children are needed.

45863733_2137002246549791_42777744774896

SIBLINGSHIP TEST

 

DNA profiling (genetic fingerprint) can be used to determine whether an individual is two or more biologically siblings. Third or more people can be added to the test. The test is obtained by applying a buccal swap (cotton-wrapped sterile plastic stick at the end of the buccal cells in the cheek) to 60 seconds into both cheeks, right and left. DNA testing is the most advanced and accurate technology that determines fraternity. it can be determined that two or more people are 99.99% biologically sibling or 0%.

45884716_2137002279883121_66674220997636

GRANDPARANTAGE TEST​

 

Grandparantage testing is the use of DNA profiling (genetic fingerprint) to determine whether an individual is biologically related to their grandparents. The test is obtained by applying a buccal swap (cotton-wrapped sterile plastic stick at the end of the buccal cells in the cheek) to 60 seconds into both cheeks, right and left. DNA testing is the most advanced and accurate technology that determines biological kinship. It can be determined that the parent is 99.99% biologically relevant to the child, and 0% not related. For this test, samples are needed as grandparents/children or grandma/children.

32557101_2010969839153033_46373380327252

WELLNESS//

 

The secret to living healthier, longer, and more athletic is on the Genetic Passport's Wellness test panel.! What is in our Genetic Passport Wellness test panel based on molecular DNA analysis of 68 gene regions?

GENETIC PREDISPOSITIONS 

 

 1) Immune System

 2) Atrial fibrillation (AF)

 3) Coronary artery disease (CAD)

 4) Intracranial aneurysm (IA)

 5) Peripheral arterial disease (PAD)

 6) Venous thromboembolism (VTE)

 7) Obesity

 8) Type 1 diabetes

 9) Type 2 diabetes

10) Hyperthyroidism

11) Folate Metabolism

12) Gluten Intolerance

13) Lactose Intolerance

14) Sugar Consumption

15) Alzheimer

16) Osteoporosis

17) Rheumatoid arthritis

18) Primary open-angle glaucoma (POAG)

19) Exfoliating glaucoma

20) Age-related macula degeneration (AMD)

21) Vitamine B12 

22) Vitamine B6

23) Vitamine D

24) Sports Performance

REPORTING

 

 

●Determining the most common 24 genetic disease risks in the world in numerical rates.

 

●Comparing personal risks with population risks numerically.

 

●Separate disclosure of the measures required to reduce the genetic and environmental risk rates for each disease.

 

●Explanation of the trigger factors one by one according to the risk rate for each disease.

 

●Descriptive information of all environmental factors necessary to minimize or even eliminate risks by risk rate for each disease.

 

●Nutritional and exercise recommendations for each disease.

 

●Emergency response warning against high-risk rates.

 

●Assessing the possibility of increased risk after the interaction of other genetic regions despite the low risk of disease.

 

●Assessing the possibility of decreasing the risk after the interaction of other genetic regions despite the high risk of disease.

PHOTO_wellnessvisit.jpg

GENETIC PASSPORT® CHECK-UP //

 

INTRODUCING THE WORLD'S MOST ADVANCED DNA TEST.

Genetic Check-Up based on molecular DNA analysis of 150 gene regions. Genetic Passport determines the risks of nearly 40 genetic diseases, ranging from cancer to Alzheimer's, sports performance to obesity, and diabetes.

GENETIC PREDISPOSITIONS

1) Breast Cancer (BC)

2) Lung Cancer (LC)

3) Colorectal Cancer (CC)

4) Gastric Cancer (GC)

5) Basal Cell Carcinoma (BCC)

6) Bladder Cancer

7) Prostate Cancer (PC)

8) Melanoma

9) Atrial fibrillation (AF)

10) Coronary artery disease (CAD)

11) Intracranial aneurysm (IA)

12) Peripheral arterial disease (PAD)

13) Venous thromboembolism (VTE)

14) Obesity

15) Type 1 diabetes

16) Type 2 diabetes

17) High blood pressure

18) Hyperthyroidism

19) Folate Metabolism

20) Gluten Intolerance

21) Lactose Intolerance

22) Sugar Consumption

23) Alzheimer

24) Osteoporosis

25) Multiple Sclerosis (MS),

26) Migraine with Aura

27) Psoriasis

28) Rheumatoid arthritis

29) The systemic lupus erythematosus (SLE)

30) Primary open-angle glaucoma (POAG)

31) Exfoliating glaucoma

32) Age-related macula degeneration (AMD)

33) Vitamine B12 

34) Vitamine B6

35) Vitamine D

36) ACTN'3 (R577X)

37) ACE (I/D) 

ANALYZED GENE REGIONS

 

Alzheimer disease APOE 
Alzheimer disease APOE 
Atrial fibrillation 4q25 
Atrial fibrillation PITX2 
Basal cell carcinoma PADI6  rs7538XXX 
Basal cell carcinoma Intergenic  rs801XXX 
Bladder cancer TACC3 
Bladder cancer MYC
Breast cancer TP53 
Breast cancer RAD51B 
Breast cancer ATM rs1800XXX
Breast cancer ATM rs1800XXX 
Breast cancer ATM rs1800XXX 
Breast cancer ATM rs1801XXX 
Breast cancer ATM rs3092XXX 
Breast cancer ATM rs3218XXX
Breast cancer ATM rs3218XXX 
Breast cancer TNRC9 
Breast cancer BRCA1 

Breast cancer ATM  
Breast cancer BRCA1 rs80357XXX 
Breast cancer BRCA2 
Celiac disease HLA-DQA1  
Celiac disease HLA-DRA  
Celiac disease Intergenic rs4639XXX
Celiac disease Intergenic rs4713XXX
Celiac disease Intergenic rs7454XXX 
Celiac disease HLA-DQB1  
Colorectal cancer SMAD7 
Colorectal cancer Intergenic rs4779XXX 
Colorectal cancer SMAD7 
Colorectal cancer Intergenic rs6983XXX 
Colorectal cancer TCF7L2 
Coronary artery disease LPA 
Coronary artery disease CDKN2B-AS1 
Coronary artery disease Intergenic rs10757XXX 
Coronary artery disease CDKN2B-AS1 rs2383XXX
Coronary artery disease CDKN2B-AS1 rs2383XXX 
Coronary artery disease LPA 
Exfoliating glaucoma LOXL1 

Exfoliating glaucoma LOXL1 rs3825XXX 
Folate Metabolizm MTHFR 
Gallstone disease ABCG8 rs11887XXX 
Gastric cancer MTHFR rs1801XXX 
Graves' disease IL-23R rs10889XXX
Graves' disease TNF-α rs1800XXX
Graves' disease TNF-α rs1800XXX
Graves' disease IL-23R rs2201XXX 
Graves' disease IL-23R rs7530XXX 
Intracranial aneurysm SOX17 rs10958XXX 
Intracranial aneurysm CDKN2A/CDKN2B 
Lactose intolerance MCM6 rs4988XXX 
Lung cancer CHRNA3 rs1051XXX 
Lung cancer HYKK rs8034XXX 
Lung cancer CHRNA5 rs951XXX 
Male pattern baldness Intergenic  
Male pattern baldness Intergenic rs6625XXX  
Melanoma MC1R rs1805XXX
Migraine with aura MTHFR rs1801XXX 
Multiple sclerosis ILR2A
Multiple sclerosis HLA-DRA

Multiple sclerosis IL7R rs6897XXX
Obesity MC4R
Obesity MC4R 
Obesity APOA2 
Obesity PCSK1
Obesity APOA5 
Obesity SH2B1 
Osteoporosis LRP5 rs3736228
Osteoporosis LRP5 rs4988321 
Peripheral arterial disease CHRNA5
Primary open angle glaucoma SIX1 
Primary open angle glaucoma ATOH7
Primary open angle glaucoma CAV1-CAV2  
Primary open angle glaucoma TMCO1 
Prostate cancer FUNDC2P2 
Prostate cancer Intergenic rs16901XXX
Prostate cancer CASC17 
Prostate cancer Intergenic
Psoriasis TNF-α 
Psoriasis LCE3D 

Rheumatoid arthritis TRAF1 
Rheumatoid arthritis Intergenic rs6457617 
Rheumatoid arthritis STAT4 
Sugar consumption SLC2A2 
Systemic lupus erythematosus STAT4 
Systemic lupus erythematosus IRF5 
Systemic lupus erythematosus ITGAM  
Systemic lupus erythematosus TNF-a  
Systemic lupus erythematosus HLA-DQA1 
Systemic lupus erythematosus SKIV2L  
Systemic lupus erythematosus STAT4 
Systemic lupus erythematosus ITGAM 
Type 1 diabetes PTPN22 
Type 1 diabetes CLEC16A 
Type 1 diabetes STAT4 
Type 1 diabetes HLA-DQA1 
Type 2 diabetes CDKN2B 
Type 2 diabetes Intergenic 
Type 2 diabetes TCF7L2 
Type 2 diabetes SLC30A8 
Type 2 diabetes PPARG

Type 2 diabetes TCF7L2 
Type 2 diabetes Intergenic 
Type 2 diabetes Intergenic 
Type 2 diabetes FTO rs9939XXX 
Venous thromboembolism F2 rs1799XXX
Venous thromboembolism F5
Vitamin B12 FUT2 
Vitamin B6 ALPL 
Vitamin D CYP2R1 
Vitamin D CYP2R1 
Vitamin D GC 
Vitamin D GC 

Muscle type ACTN3 

Cardiyac capacity ACE 

REPORTING

 

 

●Determining the most common 24 genetic disease risks in the world in numerical rates.

 

●Comparing personal risks with population risks numerically.

 

●Separate disclosure of the measures required to reduce the genetic and environmental risk rates for each disease.

 

●Explanation of the trigger factors one by one according to the risk rate for each disease.

 

●Descriptive information of all environmental factors necessary to minimize or even eliminate risks by risk rate for each disease.

 

●Nutritional and exercise recommendations for each disease.

 

●Emergency response warning against high-risk rates.

 

●Assessing the possibility of increased risk after the interaction of other genetic regions despite the low risk of disease.

 

●Assessing the possibility of decreasing the risk after the interaction of other genetic regions despite the high risk of disease.

bottom of page